BECTON, DICKINSON AND COMPANY Other Operating Activities, Cash Flow Statement
BECTON, DICKINSON AND COMPANY (BDX) reported Other Operating Activities, Cash Flow Statement of -$231.00 million for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OtherOperatingActivitiesCashFlowStatement · last filed 2026-08-06
- BECTON, DICKINSON AND COMPANY other operating activities, cash flow statement for the quarter ending 2026-06-30 was -$140.00M.
- BECTON, DICKINSON AND COMPANY other operating activities, cash flow statement for the quarter ending 2026-03-31 was -$48.00M, a 226.32% decline year-over-year.
- BECTON, DICKINSON AND COMPANY other operating activities, cash flow statement for the quarter ending 2025-12-31 was -$43.00M, a 119.91% decline year-over-year.
- BECTON, DICKINSON AND COMPANY other operating activities, cash flow statement for the quarter ending 2025-06-30 was -$165.00M, a 322.97% decline year-over-year.
| Period end | Other Operating Activities, Cash Flow Statement 3 month | Other Operating Activities, Cash Flow Statement 3 month as first filed | Other Operating Activities, Cash Flow Statement 6 month | Other Operating Activities, Cash Flow Statement 6 month as first filed | Other Operating Activities, Cash Flow Statement 9 month | Other Operating Activities, Cash Flow Statement 9 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$140.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-06 | -$188.00M derived: sum of 2 quarters · filed 2026-08-06 | -$231.00M 10-Q · filed 2026-08-06 | |||
| 2026-03-31 | -$48.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-07 | -$91.00M 10-Q · filed 2026-05-07 | ||||
| 2025-12-31 | -$43.00M 10-Q · filed 2026-02-09 | |||||
| 2025-06-30 | -$165.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-06 | -$127.00M derived: sum of 2 quarters · filed 2026-08-06 | $89.00M 10-Q · filed 2026-08-06 | $137.00M 10-Q · filed 2025-08-07 | ||
| 2025-03-31 | $38.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-07 | $254.00M 10-Q · filed 2026-05-07 | $291.00M 10-Q · filed 2025-05-01 | |||
| 2024-12-31 | $216.00M 10-Q · filed 2026-02-09 | |||||
| 2024-06-30 | $74.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-08-07 | $47.00M derived: sum of 2 quarters · filed 2025-08-07 | $45.00M 10-Q · filed 2025-08-07 | |||
| 2024-03-31 | -$27.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-01 | -$29.00M 10-Q · filed 2025-05-01 | ||||
| 2023-12-31 | -$2.00M 10-Q · filed 2025-02-06 | |||||
| 2023-06-30 | $7.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-08-01 | -$95.00M derived: sum of 2 quarters · filed 2024-08-01 | -$98.00M 10-Q · filed 2024-08-01 | |||
| 2023-03-31 | -$102.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-05-02 | -$105.00M 10-Q · filed 2024-05-02 | ||||
| 2022-12-31 | -$3.00M 10-Q · filed 2024-02-01 | |||||
| 2022-06-30 | $90.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-03 | $141.00M derived: sum of 2 quarters · filed 2023-08-03 | -$11.00M 10-Q · filed 2023-08-03 | |||
| 2022-03-31 | $51.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-05-04 | -$101.00M 10-Q · filed 2023-05-04 | ||||
| 2021-12-31 | -$152.00M 10-Q · filed 2023-02-02 | -$154.00M 10-Q · filed 2022-02-03 | ||||
| 2021-06-30 | -$312.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-04 | -$330.00M derived: sum of 2 quarters · filed 2022-08-04 | -$421.00M 10-Q · filed 2022-08-04 | -$411.00M 10-Q · filed 2021-08-05 | ||
| 2021-03-31 | -$18.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-05-05 | -$109.00M 10-Q · filed 2022-05-05 | ||||
| 2020-12-31 | -$91.00M 10-Q · filed 2022-02-03 | |||||
| 2020-06-30 | $21.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-08-05 | $124.00M derived: sum of 2 quarters · filed 2021-08-05 | -$107.00M 10-Q · filed 2021-08-05 | |||
| 2020-03-31 | $103.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-05-06 | -$128.00M 10-Q · filed 2021-05-06 | ||||
| 2019-12-31 | -$231.00M 10-Q · filed 2021-02-04 | |||||
| 2019-06-30 | -$7.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-08-06 | -$32.00M 10-Q · filed 2020-08-06 | ||||
| 2019-03-31 | -$25.00M 10-Q · filed 2020-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |